| abstract |
The present invention is particularly directed to vaccine formulations comprising split envelope virus preparations (but not split influenza virus preparations), methods of making such vaccine formulations, and disease control in the manufacture of vaccine formulations for intranasal delivery. It relates to the use of said vaccine in the prevention or treatment. |